157 related articles for article (PubMed ID: 15818610)
1. A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India.
Sankaranarayanan R; Nene BM; Dinshaw KA; Mahe C; Jayant K; Shastri SS; Malvi SG; Chinoy R; Kelkar R; Budukh AM; Keskar V; Rajeshwarker R; Muwonge R; Kane S; Parkin DM; Chauhan MK; Desai S; Fontaniere B; Frappart L; Kothari A; Lucas E; Panse N;
Int J Cancer; 2005 Sep; 116(4):617-23. PubMed ID: 15818610
[TBL] [Abstract][Full Text] [Related]
2. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
[TBL] [Abstract][Full Text] [Related]
3. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
[TBL] [Abstract][Full Text] [Related]
4. HPV screening for cervical cancer in rural India.
Sankaranarayanan R; Nene BM; Shastri SS; Jayant K; Muwonge R; Budukh AM; Hingmire S; Malvi SG; Thorat R; Kothari A; Chinoy R; Kelkar R; Kane S; Desai S; Keskar VR; Rajeshwarkar R; Panse N; Dinshaw KA
N Engl J Med; 2009 Apr; 360(14):1385-94. PubMed ID: 19339719
[TBL] [Abstract][Full Text] [Related]
5. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer screening in sub-Saharan Africa: a randomized trial of VIA versus cytology for triage of HPV-positive women.
Bigoni J; Gundar M; Tebeu PM; Bongoe A; Schäfer S; Fokom-Domgue J; Catarino R; Tincho EF; Bougel S; Vassilakos P; Petignat P
Int J Cancer; 2015 Jul; 137(1):127-34. PubMed ID: 25420434
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
Mayrand MH; Duarte-Franco E; Coutlée F; Rodrigues I; Walter SD; Ratnam S; Franco EL;
Int J Cancer; 2006 Aug; 119(3):615-23. PubMed ID: 16572425
[TBL] [Abstract][Full Text] [Related]
8. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of human papilloma virus-DNA test verses colposcopy as secondary cervical cancer screening test to triage screen positive women on primary screening by visual inspection with 5% acetic acid.
Pimple S; Shastri SS
Indian J Cancer; 2014; 51(2):117-23. PubMed ID: 25104191
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
Sarian LO; Derchain SF; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
J Med Screen; 2005; 12(3):142-9. PubMed ID: 16156945
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with a cervical high-grade lesion on cytology or a positive visual inspection with acetic acid among more than 3300 Tanzanian women.
Baldur-Felskov B; Mwaiselage J; Faber MT; Kjaerem M; de la Cour CD; Munk C; Kahesa C; Iftner T; Rasch V; Kjaer SK
Trop Med Int Health; 2019 Feb; 24(2):229-237. PubMed ID: 30444556
[TBL] [Abstract][Full Text] [Related]
12. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial.
Sankaranarayanan R; Esmy PO; Rajkumar R; Muwonge R; Swaminathan R; Shanthakumari S; Fayette JM; Cherian J
Lancet; 2007 Aug; 370(9585):398-406. PubMed ID: 17679017
[TBL] [Abstract][Full Text] [Related]
13. Is HPV DNA testing specificity comparable to that of cytological testing in primary cervical cancer screening? Results of a meta-analysis of randomized controlled trials.
Pileggi C; Flotta D; Bianco A; Nobile CG; Pavia M
Int J Cancer; 2014 Jul; 135(1):166-77. PubMed ID: 24302411
[TBL] [Abstract][Full Text] [Related]
14. Early detection of cervical cancer with visual inspection methods: a summary of completed and on-going studies in India.
Sankaranarayanan R; Nene BM; Dinshaw K; Rajkumar R; Shastri S; Wesley R; Basu P; Sharma R; Thara S; Budukh A; Parkin DM
Salud Publica Mex; 2003; 45 Suppl 3():S399-407. PubMed ID: 14746033
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa.
Sankaranarayanan R; Basu P; Wesley RS; Mahe C; Keita N; Mbalawa CC; Sharma R; Dolo A; Shastri SS; Nacoulma M; Nayama M; Somanathan T; Lucas E; Muwonge R; Frappart L; Parkin DM;
Int J Cancer; 2004 Jul; 110(6):907-13. PubMed ID: 15170675
[TBL] [Abstract][Full Text] [Related]
16. Initial results from a randomized trial of cervical visual screening in rural south India.
Sankaranarayanan R; Rajkumar R; Theresa R; Esmy PO; Mahe C; Bagyalakshmi KR; Thara S; Frappart L; Lucas E; Muwonge R; Shanthakumari S; Jeevan D; Subbarao TM; Parkin DM; Cherian J
Int J Cancer; 2004 Apr; 109(3):461-7. PubMed ID: 14961588
[TBL] [Abstract][Full Text] [Related]
17. Implementing community-based cervical cancer screening programs using visual inspection with acetic acid in India: A systematic review.
Adsul P; Manjunath N; Srinivas V; Arun A; Madhivanan P
Cancer Epidemiol; 2017 Aug; 49():161-174. PubMed ID: 28704717
[TBL] [Abstract][Full Text] [Related]
18. Cervical screening by visual inspection with acetic acid (VIA) is well accepted by women--results from a community-based study in rural India.
Basu P; Ghoshal M; Chattopadhyay K; Mittal S; Das P; Choudhury D; Chattopadhyay U
Asian Pac J Cancer Prev; 2006; 7(4):604-8. PubMed ID: 17250436
[TBL] [Abstract][Full Text] [Related]
19. Cervical cancer screening with naked-eye visual inspection in Colombia.
Murillo R; Luna J; Gamboa O; Osorio E; Bonilla J; Cendales R;
Int J Gynaecol Obstet; 2010 Jun; 109(3):230-4. PubMed ID: 20347442
[TBL] [Abstract][Full Text] [Related]
20. Determinants of womens participation in cervical cancer screening trial, Maharashtra, India.
Nene B; Jayant K; Arrossi S; Shastri S; Budukh A; Hingmire S; Muwonge R; Malvi S; Dinshaw K; Sankaranarayanan R
Bull World Health Organ; 2007 Apr; 85(4):264-72. PubMed ID: 17546307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
